3 Undervalued Small Caps With Insider Buying Across Regions

Simply Wall St.11-21 19:02

In the current global market landscape, small-cap stocks have experienced a mixed performance, with the Russell 2000 index showing a decline amidst broader market volatility influenced by political ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2485461133?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ilz_QRJfue4O96SgMglUEQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/26cebba865ed1d4633d2eacc31dceb62","is_english":true,"pubTime":"2024-11-21 19:02","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2485461133","market":"us","top_or_hot":-1,"title":"3 Undervalued Small Caps With Insider Buying Across Regions","media":"Simply Wall St.","content":"<div>\n<p>In the current global market landscape, small-cap stocks have experienced a mixed performance, with the Russell 2000 index showing a decline amidst broader market volatility influenced by political ...</p>\n\n<a href=\"https://finance.yahoo.com/news/3-undervalued-small-caps-insider-110204198.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Undervalued Small Caps With Insider Buying Across Regions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Undervalued Small Caps With Insider Buying Across Regions\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-21 19:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/3-undervalued-small-caps-insider-110204198.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In the current global market landscape, small-cap stocks have experienced a mixed performance, with the Russell 2000 index showing a decline amidst broader market volatility influenced by political ...</p>\n\n<a href=\"https://finance.yahoo.com/news/3-undervalued-small-caps-insider-110204198.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XVIPF","symbol_name":"Xvivo Perfusion AB","start_time":0,"source_url":"https://finance.yahoo.com/news/3-undervalued-small-caps-insider-110204198.html","article_id":"2485461133","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ilz_QRJfue4O96SgMglUEQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/26cebba865ed1d4633d2eacc31dceb62"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2485461133","pubTimestamp":1732186924,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"In the current global market landscape, small-cap stocks have experienced a mixed performance, with the Russell 2000 index showing a decline amidst broader market volatility influenced by political changes and economic indicators. As investors navigate these uncertain times, identifying undervalued small-cap companies with insider buying can signal potential opportunities for growth, as such actions often reflect confidence from those closest to the company in its future prospects.Click here to see the full list of 171 stocks from our Undervalued Small Caps With Insider Buying screener.Xvivo Perfusion, a player in the medical technology sector, showcases promising growth with earnings projected to rise by 24.61% annually. Recent financials highlight significant improvement; third-quarter sales reached SEK 198 million, up from SEK 147 million last year, and net income soared to SEK 86 million from just SEK 2 million. Despite relying entirely on external borrowing for funding, insider co","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"XVIPF":"Xvivo Perfusion AB","BK4588":"碎股","BK4198":"医疗保健用品","BK4211":"区域性银行","XVIPY":"Xvivo Perfusion AB","RF":"地区金融","BK4585":"ETF&股票定投概念"},"translate_title":"3只被低估的小盘股，跨地区内部人士买入","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RF":1,"XVIPF":0.9,"XVIPY":0.9},"content_text":"In the current global market landscape, small-cap stocks have experienced a mixed performance, with the Russell 2000 index showing a decline amidst broader market volatility influenced by political changes and economic indicators. As investors navigate these uncertain times, identifying undervalued small-cap companies with insider buying can signal potential opportunities for growth, as such actions often reflect confidence from those closest to the company in its future prospects.\nTop 10 Undervalued Small Caps With Insider Buying\n\n\n\nName\nPE\nPS\nDiscount to Fair Value\nValue Rating\n\n\nSagicor Financial\n1.2x\n0.3x\n35.19%\n★★★★★★\n\n\nParadeep Phosphates\n23.6x\n0.8x\n29.71%\n★★★★★☆\n\n\nPSC\n7.5x\n0.4x\n43.98%\n★★★★☆☆\n\n\nAvia Avian\n16.6x\n3.8x\n9.50%\n★★★★☆☆\n\n\nTrican Well Service\n8.3x\n1.0x\n14.87%\n★★★★☆☆\n\n\nRogers Sugar\n15.6x\n0.6x\n47.45%\n★★★★☆☆\n\n\nNCL Industries\n14.8x\n0.5x\n-81.34%\n★★★☆☆☆\n\n\nSemen Indonesia (Persero)\n20.8x\n0.7x\n29.48%\n★★★☆☆☆\n\n\nL.G. Balakrishnan & Bros\n13.7x\n1.6x\n-36.57%\n★★★☆☆☆\n\n\nCommunity West Bancshares\n18.7x\n2.9x\n42.25%\n★★★☆☆☆\n\n\n\n Click here to see the full list of 171 stocks from our Undervalued Small Caps With Insider Buying screener. \nWe'll examine a selection from our screener results.\nXvivo Perfusion\nSimply Wall St Value Rating: ★★★☆☆☆\nOverview: Xvivo Perfusion specializes in developing and providing advanced medical technologies for organ transplantation, with a market cap of approximately SEK 6.48 billion.\nOperations: Xvivo Perfusion generates revenue primarily from its Thoracic, Abdominal, and Services segments. The company has experienced fluctuations in its net income margin, with a notable increase to 27.21% by September 2024. Operating expenses have consistently been a significant component of the cost structure, driven by sales and marketing as well as research and development activities.\nPE: 68.9x\nXvivo Perfusion, a player in the medical technology sector, showcases promising growth with earnings projected to rise by 24.61% annually. Recent financials highlight significant improvement; third-quarter sales reached SEK 198 million, up from SEK 147 million last year, and net income soared to SEK 86 million from just SEK 2 million. Despite relying entirely on external borrowing for funding, insider confidence is evident through recent purchases. The appointment of Lena Hagman as deputy CEO adds strategic depth to its leadership team.\n\nDive into the specifics of Xvivo Perfusion here with our thorough valuation report.\nReview our historical performance report to gain insights into Xvivo Perfusion's's past performance.\n\n\n\n\n  OM:XVIVO Share price vs Value as at Nov 2024\n \n\nCutia Therapeutics\nSimply Wall St Value Rating: ★★★★☆☆\nOverview: Cutia Therapeutics is a company focused on developing innovative and comprehensive solutions, with operations contributing to a market capitalization of CN¥3.45 billion.\nOperations: The company generates revenue primarily from developing innovative and comprehensive solutions, with recent figures reaching CN¥198.86 million. Over the observed periods, the gross profit margin has shown a declining trend from 78.99% to 50.33%. Operating expenses are significant, with research and development costs consistently high, alongside substantial sales and marketing expenditures. The net income margin reflects ongoing challenges in achieving profitability despite revenue growth.\nPE: -4.5x\nCutia Therapeutics, a small player in the biotech sector, recently received marketing approval for its innovative CU-10201 topical minocycline foam in China, marking a significant milestone. The company reported impressive revenue growth of 129.9% for the first nine months of 2024 compared to the previous year. Despite being currently unprofitable and relying on external borrowing, insider confidence is evident as Yuqing Huang purchased 35,000 shares worth approximately RMB 421,697 between September and November 2024.\n\nClick here to discover the nuances of Cutia Therapeutics with our detailed analytical valuation report.\nGain insights into Cutia Therapeutics' historical performance by reviewing our past performance report.\n\n\n\n\n  SEHK:2487 Share price vs Value as at Nov 2024\n \n\nShougang Fushan Resources Group\nSimply Wall St Value Rating: ★★★☆☆☆\nOverview: Shougang Fushan Resources Group is engaged in coking coal mining operations with a focus on producing and selling coking coal, boasting a market capitalization of HK$12.34 billion.\nOperations: The primary revenue stream is from coking coal mining, with recent revenue reported at HK$4.95 billion. The gross profit margin has shown fluctuations, most recently recorded at 53.36%. Operating expenses include significant allocations to general and administrative as well as sales and marketing expenses.\nPE: 9.2x\nShougang Fushan Resources Group, a smaller company in the resource sector, recently completed a follow-on equity offering of HK$427 million. Despite declining sales and net income for the first half of 2024 compared to last year, with sales at HK$2.5 billion and net income at HK$837 million, insider confidence is evident as they continue purchasing shares. The appointment of Mr. Li Zeping as an independent director could enhance governance amid challenging earnings forecasts over the next few years.\n\nClick to explore a detailed breakdown of our findings in Shougang Fushan Resources Group's valuation report.\nLearn about Shougang Fushan Resources Group's historical performance.\n\n\n\n\n  SEHK:639 Share price vs Value as at Nov 2024\n \n\nWhere To Now?\n\nUnlock our comprehensive list of 171 Undervalued Small Caps With Insider Buying by clicking here.\nAlready own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.\nSimply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.\n\nCurious About Other Options?\n\nExplore high-performing small cap companies that haven't yet garnered significant analyst attention.\nFuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.\nFind companies with promising cash flow potential yet trading below their fair value.\n\n This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.\nCompanies discussed in this article include OM:XVIVO SEHK:2487 and SEHK:639.\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2485461133"}